Jazz Pharmaceuticals PLC (JAZZ) — Strategic Asset Allocation Index
Jazz Pharmaceuticals PLC (JAZZ) has a Strategic Asset Allocation Index of 8.2% as of September 2023. Strategic assets (PP&E of $287.51 Million plus long-term investments of $-) total $287.51 Million, measured against net assets of $3.49 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See JAZZ equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Jazz Pharmaceuticals PLC Strategic Asset Allocation Index (2007–2022)
This chart shows how Jazz Pharmaceuticals PLC's Strategic Asset Allocation Index has evolved across 14 annual periods from 2007 to 2022. As of September 2023, the index stands at 8.2%, representing strategic assets of $287.51 Million against net assets of $3.49 Billion USD. For live market cap and overall valuation, see JAZZ market cap.
Annual Strategic Asset Allocation Index for Jazz Pharmaceuticals PLC (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jazz Pharmaceuticals PLC from 2007 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See JAZZ net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 9.8% | $301.38 Million | $301.38 Million | $- | $3.09 Billion | ▲ +1.1 pp |
| 2021 | 8.7% | $343.42 Million | $343.42 Million | $- | $3.97 Billion | ▲ +5.2 pp |
| 2020 | 3.5% | $127.94 Million | $127.94 Million | $- | $3.66 Billion | ▼ -5.4 pp |
| 2019 | 8.9% | $275.39 Million | $270.89 Million | $4.50 Million | $3.11 Billion | ▲ +1.3 pp |
| 2018 | 7.5% | $207.00 Million | $200.36 Million | $6.64 Million | $2.76 Billion | ▲ +1.2 pp |
| 2017 | 6.3% | $172.22 Million | $170.08 Million | $2.14 Million | $2.71 Billion | ▲ +0.6 pp |
| 2016 | 5.7% | $107.49 Million | $107.49 Million | $- | $1.88 Billion | ▲ +0.4 pp |
| 2015 | 5.4% | $85.57 Million | $85.57 Million | $- | $1.60 Billion | ▲ +1.1 pp |
| 2014 | 4.3% | $58.36 Million | $58.36 Million | $- | $1.37 Billion | ▲ +3.2 pp |
| 2013 | 1.1% | $14.25 Million | $14.25 Million | $- | $1.30 Billion | ▲ +0.5 pp |
| 2012 | 0.6% | $7.28 Million | $7.28 Million | $- | $1.12 Billion | ▼ -0.2 pp |
| 2011 | 0.8% | $1.56 Million | $1.56 Million | $- | $192.79 Million | ▼ -1.5 pp |
| 2010 | 2.3% | $690.00K | $690.00K | $- | $30.55 Million | ▼ -4.9 pp |
| 2007 | 7.2% | $3.94 Million | $3.94 Million | $- | $54.99 Million | — |